Multi‑mechanical waves against Alzheimer’s disease pathology: a systematic review by Monteiro, Francisca Machado et al.
Monteiro  et al. Transl Neurodegener           (2021) 10:36  
https://doi.org/10.1186/s40035-021-00256-z
REVIEW
Multi-mechanical waves against Alzheimer’s 
disease pathology: a systematic review
Francisca Monteiro1,3*† , Ioannis Sotiropoulos2,3,4†, Óscar Carvalho1, Nuno Sousa2,3 and Filipe S. Silva1 
Abstract 
Alzheimer’s disease (AD) is the most common cause of dementia, affecting approximately 40 million people world-
wide. The ineffectiveness of the available pharmacological treatments against AD has fostered researchers to focus 
on alternative strategies to overcome this challenge. Mechanical vibrations delivered in different stimulation modes 
have been associated with marked improvements in cognitive and physical performance in both demented and non-
demented elderly. Some of the mechanical-based stimulation modalities in efforts are earlier whole-body vibration, 
transcranial ultrasound stimulation with microbubble injection, and more recently, auditory stimulation. However, 
there is a huge variety of treatment specifications, and in many cases, conflicting results are reported. In this review, 
a search on Scopus, PubMed, and Web of Science databases was performed, resulting in 37 papers . These studies 
suggest that mechanical vibrations delivered through different stimulation modes are effective in attenuating many 
parameters of AD pathology including functional connectivity and neuronal circuit integrity deficits in the brains of 
AD patients, as well as in subjects with cognitive decline and non-demented older adults. Despite the evolving pre-
clinical and clinical evidence on these therapeutic modalities, their translation into clinical practice is not consolidated 
yet. Thus, this comprehensive and critical systematic review aims to address the most important gaps in the reviewed 
protocols and propose optimal regimens for future clinical application.
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Introduction
Alzheimer’s disease (AD) is an age-related neurodegen-
erative disorder characterized by progressive structural 
and functional lesions in the brain, which include neu-
ronal atrophy and synaptic loss accompanied by neuronal 
death, brain network damage, and aberrant network 
oscillations [1]. These brain lesions are correlated with 
the accumulation and aggregation of amyloid β (Aβ) pep-
tide and Tau protein [2–4], resulting in extracellular Aβ 
plaques and intracellular neurofibrillary tangles of hyper-
phosphorylated Tau protein in the AD brain [5, 6]. This 
disorder is clinically characterized by evolving memory 
impairments followed by broad cognitive decline and 
brain degeneration that ultimately leads to death. AD 
appears to be a devastating disorder that affects approxi-
mately 40 million people worldwide while this number 
is expected to be triplicated by 2050 [7, 8]. Based on its 
increasing incidence and high societal impact, the World 
Health Organization has declared AD and dementia a 
major priority health issue [8]. However, besides the 
extensive efforts over years to find a pharmacological 
treatment for AD, there is no effective therapy that can 
stop or revert brain pathology as well as cognitive and 
other behavioral deficits of AD [9].
Recently, alternative therapeutic strategies (e.g. elec-
trical-, magnetic-, optical- and mechanical-based thera-
pies) for AD have been intensively investigated [10–12]. 
Among the most promising ones, the mechanical wave-
based modalities acting at different vibration modes have 
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been associated with improvement of AD neuropathol-
ogy beyond the reduction of Aβ and Tau accumulation, 
affecting various pathological parameters involved in AD 
such as chronic neuroinflammation, synaptic loss, and 
neuronal atrophy; importantly, these alterations are also 
accompanied by an attenuation of cognitive and other 
behavioral deficits. These modalities are non-invasive, 
low-cost, and easily customized brain stimulation tech-
niques that include whole-body vibration (WBV), tran-
scranial ultrasound stimulation (TUSS), and auditory 
stimulation (AS). The WBV training consists of passive 
exercise training delivered by a vibratory platform [13, 
14] and has been associated with numerous beneficial 
effects on neuromuscular function [15–17], vascular dis-
eases [18], and neurological conditions [19, 20] in older 
adults. During the last five years, a few studies have tested 
WBV in demented or AD patients,  showing promis-
ing results [21, 22]. Moreover, the use of TUSS, another 
mechanical-based modality, in experimental animals has 
also provided some solid evidence on its beneficial effects 
on brain plasticity and function as well as  neuronal cir-
cuit integrity in young wild-type animals [23–29]. More 
recent studies support the use of the AS, a sensory-based 
stimulation strategy delivered by trains of tones, as a 
potential solution to entrain gamma oscillation in the 
brains of AD transgenic mice, which has been shown to 
reduce AD neuropathology and behavioral impairment 
[30, 31].
These mechanical-based therapeutic modalities are in 
the early exploration of alternative therapies to attenu-
ateAD pathology and associated behavioral deficits. 
Although they share the same fundamental energy-trans-
fer carrier (which is the mechanical waves), the stimula-
tion modalities require different application protocols 
and acoustic/mechanical parameters, and therefore dis-
tinct specifications must be considered. In addition, there 
is a huge variety of treatment specifications within the 
same stimulation protocols, and in many cases, conflict-
ing results are reported. Thus, this systematic review aims 
to evaluate and critically discuss the existing evidence 
on these multi-mechanical wave-based stimuli and their 
impact on different aspects of AD pathology, but also on 
age-related impairments that often occur concomitantly 
with the development of AD and related dementia (e.g., 
impairments in neuromuscular function and mobility).
Methods
This systematic review was conducted according to the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines.
Search strategy
The electronic search was performed in Scopus, PubMed, 
and Web of Science databases by the date of 26 Decem-
ber 2020. The following search terms were employed: 
("Alzheimer’s disease" OR "cognitive decline" OR “mild 
cognitive impairment”) AND (“music therapy” OR 
“acoustic wave” OR “acoustic stimulation” OR “auditory 
stimulation” OR “sound stimulation” OR “somatosensory 
stimulation” OR “whole-body vibration”  OR “vibration 
therapy” OR “sound wave” OR “mechanical wave” OR 
“rhythmic sensory stimulation” OR “vibroacoustic ther-
apy” OR “vibrotactile stimulation” OR “physioacoustic 
therapy” OR “binaural beats” OR “tone stimulation” OR 
“scanning ultrasound” OR “focused ultrasound” OR "son-
ication" OR “ultrasonic therapy”).
Eligibility criteria
The established requirements for eligibility are depicted 
in Table 1. Titles and abstracts were screened and filtered 
according to the criteria.
Quality assessment
In line with previous systematic reviews in AD [32, 33], 
the quality assessment of the reviewed clinical studies 
was performed using the Effective Public Health Prac-
tice Project (EPHPP) Quality Assessment Tool, and 
classified according to their global rating as having low 
(no “Weak” ratings), moderate (one “Weak” rating) or 
high (two or more “Weak” ratings) risk of bias [34]. For 
Table 1 Eligibility criteria for admission in this review
Inclusion criteria Exclusion criteria
Preclinical and clinical studies reporting noninvasive application of 
mechanical vibration-based approaches to impact AD pathology and/or 
related symptoms
Preclinical and clinical studies reporting the application of mechanical 
vibration-based approaches to impact physical and/or cognitive deficits in 
aged animal models or non-demented older adults (aged over 60 years)
Studies written in English
Reviews, conference papers, proceedings papers, editorials, and surveys
Studies reporting the use of mechanical waves to facilitate/interfere with 
drug/gene delivery into the brain
Studies in which mechanical stimulation is combined with other (unusual) 
interventions/activities (e.g., physical exercise)
Studies in which nonperiodic mechanical waves are used to stimulate the 
brain
Studies that evaluate the effect of mechanical stimulation in individuals 
suffering from cognitive decline derived from other diseases/conditions 
(e.g., stroke, ischemia, Parkinson’s disease)
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animal studies, the Stroke Therapy Academic Industry 
Roundtable (STAIR) preclinical recommendations were 
used [35]. Each study was assessed independently by two 
authors (FM and OC) and, when different results were 
achieved, the authors reevaluated the original paper 
until reaching a consensus. Complete quality assessment 
data, including the defined criteria, the results for each 
study, and their categorization, are provided as Addi-
tional file 1.
Results
Article selection and quality assessment
The electronic literature search resulted in 1860 publica-
tions, and other 14 papers found in the literature review 
were added to the study list; then 649 duplicates were 
removed. By screening the titles and abstracts of the 
remaining 1225 titles, 168 full-text articles were assessed 
for eligibility, and 37 of them met the defined criteria and 
were included in the current systematic review. The arti-
cle selection process is schematized in Fig. 1.
Concerning the methodological quality assessment, 
the EPHPP Quality Assessment Tool classified 17 clini-
cal studies (nWBV = 10, nTUSS = 3, nAS = 4) as having low 
risk of bias, three WBV and one TUSS studies were clas-
sified as having a moderate risk of bias, and only two 
studies presented a high risk of bias (two WBV papers). 
For the animal studies, the STAIR preclinical recommen-
dations showed that the overall quality was not satisfac-
tory; none of the included studies performed a sample 
size calculation, only one correctly described the method 
Fig. 1 Flowchart of the article selection process. Adapted from [101]
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of allocation concealment [36], only two studies reported 
the reasons for animal exclusion from analysis [37, 38], 
and the majority of them did not mention the existence 
of any exclusion at all. Although many studies state that 
the animals were randomly allocated to the experimen-
tal groups, only one study provided details about the 
method of randomization [37]. The overall quality assess-
ment data are presented in Additional file  1: Tables S1 
and S2.
Profile of the included articles
This systematic review focuses on both preclinical and 
clinical studies that used three types of mechanical vibra-
tion-based stimulation: WBV (n = 14, Table  2), TUSS 
(n = 17, Table 3), and AS (n = 6, Table 4).
At the clinical level, the effect of WBV training was 
assessed in cohorts of non-demented older adults 
(n = 11) or individuals diagnosed with mild or moder-
ate dementia (n = 3) using different cognitive status tests 
such as Cantonese mini-mental state examination and 
Mini-Mental State Examination.
The TUSS and AS studies included in this systematic 
review describe both preclinical and clinical evidence. 
Regarding the 17 TUSS studies, five of them were dedi-
cated to the investigation of the effectiveness of com-
bined ultrasound treatment and microbubble injection 
in AD patients; the remaining TUSS studies were con-
ducted in AD transgenic mouse models (n = 11) and aged 
amyloid-β (Aβ)-positive dogs (n = 1).
For AS papers, two animal studies were performed in 
AD transgenic mice using periodic stimuli while one of 
them combined AS with visual stimulation. The remaining 
four AS studies were performed in humans using hetero-
geneous protocols; one study provided vibroacoustic stim-
ulation (i.e., therapeutic strategy using vibratory sound 
stimuli) to AD patients; another study tested the effect of 
combined auditory and visual stimuli in AD patients, and 
the other two studies described the implementation of 
an AS protocol during sleep in amnestic mild cognitive 
impairment (MCI) patients (i.e. a prodromal stage of AD) 
and healthy non-demented older subjects.
The data collected from the included studies are organ-
ized in Tables 2, 3 and 4, summarizing the implemented 
protocols and the most important findings from the WBV, 
TUSS, and AS studies, respectively. The studies are com-
piled in chronological order, starting with animal studies, 
followed by clinical trials. The readouts used in the origi-
nal papers are categorized and compared in Table 5.
Basic principles of the three mechanical‑based modalities 
and their relationship to brain pathology
WBV training consists of passive exercise training deliv-
ered by a vibratory platform in which   high-frequency 
(5–40  Hz) and small-amplitude mechanical stimuli are 
applied to the entire body [13, 14]. During WBV train-
ing, the vibration delivered by the oscillating platform 
stimulates the neuromuscular system by activating mus-
cles through spinal reflexes and increasing synchronous 
motor unit recruitment [39]. These phenomena enhance 
neuromuscular excitability, inducing muscle contrac-
tions [39, 40], which has been shown to produce numer-
ous beneficial effects in older adults on neuromuscular 
function [15–17], vascular diseases [18], and neurologi-
cal conditions [19, 20]. However, despite the wide range 
of clinical application, limited doses of WBV are well 
tolerated by the elderly, as overexposure to WBV train-
ing can result in over-stress injuries [14]. On the other 
hand, insufficient stimulation may result in the lack of the 
desired improvement. For this reason, the dose–response 
relationship for WBV needs to be carefully defined for 
each application or individual (including an AD patient-
tailored procedure), and no optimal protocols have yet 
been established.
TUSS is a modality used in combination with micro-
bubble injection, which transiently opens the blood–
brain barrier (BBB). After intravenous injection in the 
brain, the ultrasound (US)-sonicated microbubbles 
undergo expansion–contraction cycles that disrupt 
the tight junctions along the blood vessel walls, creat-
ing new entries through the BBB [41], usually reversed 
within 24  h. Importantly, the size and dose of micro-
bubbles, as well as their manipulation and synchroniza-
tion with sonication must be appropriate to allow the 
efficiency and success of the process. Also, ultrasonic 
waves are mainly characterized via the center frequency 
(associated with the energy carried by the waves), the 
emission mode (i.e., continuous or pulsed mode), and 
the power density or pressure that is applied to a cer-
tain body/surface (associated with the intensity of the 
stimulation). The TUSS microbubble-assisted approach 
has been widely used in the last decade to facilitate the 
delivery of therapeutic agents for the treatment of a 
wide range of neurological disorders, showing promis-
ing efficiency to facilitate their pharmacological effect 
[42–45]. However, recent studies have shown the ben-
eficial action of TUSS (i.e. without association to any 
drug) to stimulate neurogenesis, neuronal excitability, 
and/or brain network activity in wild-type experimen-
tal animals [23–29] and improve AD brain pathol-
ogy and related memory deficits in AD mouse models 
[23–29, 46, 47]. These achievements have sparked clini-
cal interest in the pursuit of an effective noninvasive 
intervention based on the transcranial application of 
US to ameliorate AD pathology. Yet, the novelty of this 
technique entails many doubts concerning the optimal 
Page 5 of 28Monteiro  et al. Transl Neurodegener           (2021) 10:36  
protocols and the long-term effects as discussed below 
(see  Section Limitations and future directions).
More recently, AS has been receiving increased atten-
tion due to its effectiveness in reducing Aβ and Tau 
pathology and  improving cognitive abilities in AD ani-
mal models [30, 48]. This is a sensory-based stimulation 
strategy delivered by trains of tones repeated at a spe-
cific frequency which has been associated with marked 
entrainment of brainwaves in the brains of AD trans-
genic mice [30, 48] and AD patients [31, 49]. In fact, Aβ 
and Tau pathologies are known to alter brain rhythmic 
oscillatory activities [50], mainly in high-frequency band 
waves, impacting the high-order cognitive domains [51, 
52]. High-frequency brainwaves, e.g. gamma oscillations 
(30–100 Hz), are disrupted in both AD patients and AD 
transgenic mouse models [51, 53]. During the last years, 
sensory stimulation has been used to affect/stimulate 
gamma band oscillations in the brain. Importantly, this 
brainwave entrainment has been correlated with the 
attenuation of AD pathomechanisms in AD mouse mod-
els [51, 54], as well as with the improvement of cognitive 
function and sleep disturbances in younger adults [55].
Impact on AD pathomechanisms and associated brain 
malfunction
This section presents and discusses findings from studies 
on the three modalities (Tables 2, 3, 4), classified into cel-
lular, molecular, brain function/connectivity  and behav-
ioral outputs.
Aβ and Tau pathologies
In WBV studies, no biochemical or brain imaging analy-
sis was performed to assess possible alterations of Aβ 
and/or Tau pathology in the brains of participants. On 
the other hand, the reviewed studies on TUSS and AS 
provide plenty of preclinical evidence on their effec-
tiveness to reduce/block Aβ and Tau accumulation and 
aggregation.
TUSS Ultrasound pulses delivered transcranially 
inhibit the formation of Aβ plaques by decreasing solu-
ble Aβ species, as shown in the brains of three differ-
ent AD transgenic mouse models with advanced Aβ 
pathology, i.e. APP23, 3xTg, and 5xFAD [36, 56–58]. 
In some cases, pulsed TUSS is able to markedly reduce 
Aβ plaque load (affecting number, size, area) in differ-
ent AD transgenic mice after single [37, 59] or multiple 
US sessions [36, 37, 57, 58, 60, 61]. It should be noted 
that these studies have typically used similar stimula-
tion frequencies (center frequency ̴ 1  MHz, pulsing at 
1–10 Hz), but very discrepant duration (few minutes to 
1 h for each session, delivered either in a single appli-
cation or over several weeks). Moreover, two stud-
ies in Aβ-based transgenic mice (i.e., TgCRND8) with 
abundant amyloid plaque load reported that part of the 
TUSS beneficial effect was lost when follow-up periods 
were considered; both Jordão et  al. (2013) and Poon 
et  al. (2018) reported that the reduction of Aβ plaque 
area was observed four to seven days after mouse brain 
stimulation, but this recovery was lost two weeks after a 
single session of 2 min [37] or 8 min [59]. Another study 
in aged Aβ-positive dogs showed a tendency for reduced 
Aβ load in the prefrontal cortex of the US-treated hemi-
sphere, in both single- and multiple-session interven-
tions [62]. This limited impact of TUSS treatment on 
Aβ load could be attributed to the insufficient stimulus 
duration or intensity (such as insufficient duration of 
each stimulation, e.g. 2  min stimulation once a week, 
4 weeks period, or insufficient ultrasonic intensity, e.g. 
0.28  MHz pulsing at 1  Hz, as the center frequency is 
relatively lower compared to all the other preclinical 
experiments in AD transgenic mice). Another param-
eter to be considered is the advanced state of Aβ pathol-
ogy of the experimental animals (dogs in the above 
study), which may suggest that such applications should 
be more beneficial if they are offered in early stages of 
AD brain pathology [62].
At the clinical level, only two studies have investi-
gated the effect of TUSS on Aβ in the brains of mild-
to-moderate AD patients (aged 57–73  years), by using 
 [18F]-florbetaben PET scan [63, 64]. However, conflict-
ing outcomes have been reported. The first study by 
Lipsman and colleagues (2018) found no significant 
alterations in Aβ level after TUSS treatment (7.5  min 
once a week, 3  months period) delivered using a hel-
met-like device (whole-brain stimulation) in mild-to-
moderate AD patients [63]. On the contrary, D’Haese 
et al. (2020) reported a reduction of Aβ plaques in the 
hippocampus and entorhinal cortex of the treated hem-
isphere after unilateral stimulation (3 sessions, 6 weeks 
period) in patients at early stage of AD and at a similar 
age [65].
Although less studied, the beneficial effect of TUSS on 
Tau hyperphosphorylation and aggregation has recently 
emerged. Experimental studies have described a TUSS-
driven decrease of p-Tau levels in the hippocampus of 
three different mutant-Tau transgenic mouse models (i.e., 
K3, rTg4510, and 3xTg-AD mice) after single [45, 58] or 
multiple US sonications (2.4 min once a week, 15 weeks 
period) [66]. Reduction is also observed for neurofibril-
lary tangles, the final intraneuronal aggregates of Tau, 
in K3 mice [66]. Interestingly, Karakatsani et  al. (2019) 
observed a reduction of p-Tau in both hemispheres of 
4-month-old rTg4510 mouse brain after a single ses-
sion of unilateral-target US sonication [45], showing that 
US is capable of producing a widespread and systemic 
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response across the brain beyond the sonicated areas, 
even with a minimum dose of TUSS (1-min session).
AS For AS, only preclinical studies have monitored its 
effect on Aβ load, using trains of tones repeating at 40 Hz. 
In the study conducted by Martorell et  al. (2019), the 
trains of acoustic tones (1  h/day, 7  days period) evoked 
the clearance of Aβ soluble species and the decrease of 
Aβ plaques in the auditory cortex and hippocampus of 
5xFAD and APP/PS1 mice; both mouse models exhibit 
marked Aβ plaque burden [30]. Similar results were found 
in another study [48] that used a longer stimulation pro-
tocol (2 h/day, 15 days period) and reported that 40-Hz 
AS stimulation decreased both soluble and insoluble Aβ 
species, accompanied by a reduction in Aβ plaque num-
ber throughout the brains of 5xFAD mice [48]. Inter-
estingly, when AS was combined with another sensory 
modality (visual stimulation using light flickering at the 
same rate—40  Hz), a wider effect was produced across 
the brain, which exhibited reduced Aβ pathology not only 
in the auditory cortex and hippocampus but also in the 
medial prefrontal cortex of 5xFAD mice [30].
In addition, only one study has reported a beneficial 
impact of AS on Tau pathology. By applying 40-Hz AS, 
Martorell and his collaborators (2019) observed a reduc-
tion in Tau hyperphosphorylation and seeding in the 
auditory cortex and hippocampus of P301S-Tau trans-
genic mice (1 h/day, 7 days period) [30]. No clinical evi-
dence exists on the effectiveness of mechanical vibrations 
using any of the reviewed stimulation modes in mitigat-
ing Tau phosphorylation and accumulation in the AD 
human brain.
Immunological response
Among the reviewed studies performed in experi-
mental models, 11 out of 14 have reported a positive 
immunological response induced by ultrasonic waves 
or AS. Again, no clinical evidence exists on the immu-
nomodulation in the brains of AD patients or healthy, 
non-demented individuals under the three types of stim-
ulation reviewed here.
TUSS The reviewed studies present conflicting out-
comes concerning the effect of TUSS on the activity of 
glial cells (i.e., microglia, astrocytes, or macrophages) in 
the brains of AD transgenic mice. Most of the preclinical 
TUSS studies have reported activation of immune cells 
after treatment and their increased co-localization/inter-
nalization of Aβ [36, 56–61] or Tau [45] fragments in the 
brains of AD transgenic models. It is worthy to note that, 
despite the microglial activation (e.g., extended branch-
ing) after ultrasonic treatment, Leinenga and Gotz (2015) 
observed no alterations in inflammatory markers in the 
brains of aged APP23 mice (which exhibit pronounced Aβ 
plaques) after US (once per week, 4 or 7  weeks period) 
[36]. On the other hand, two studies have reported a 
reduction in gliosis ( by  assessment of glial fibrillary 
acidic protein [GFAP] [56] and ionized calcium-binding 
adaptor molecule 1 [Iba1] [56, 57]) in the brains of AD 
mouse models, either after a single TUSS session of 1 min 
(marked effect in the hippocampus and entorhinal cortex 
of 5xFAD mice) [56], or after a repetitive TUSS treatment 
(3 sessions/20 min each on alternate days, the first week 
of each month for three months) [57]. Note that the latter 
study used a significantly higher pulsing rate (6 kHz) and 
longer treatment duration compared to the others and 
found a unique regulation of some immune-related genes 
(e.g., GFAP, Olig2, and CXC chemokine receptor 4) in the 
brains of 5xFAD mice after US treatment [57].
Moreover, Jordão et al. (2013) have demonstrated that 
TUSS (single session of 8  min) increases the bioavail-
ability of endogenous antibodies (i.e. immunoglobulins 
G and M) in the brains of Aβ-based transgenic mice 
(TgCRND8), and also promotes the interaction of these 
antibodies with Aβ plaques, thereby facilitating the 
clearance of their aggregates from the brain [59]. The 
increased antibody bioavailability is also accompanied by 
a phagocytic response of glial cells towards Aβ aggregates 
in both US-treated and non-treated brain hemispheres 
[59], which is in line with previous reports supporting 
a US-induced systemic bioeffect in brain areas beyond 
the one that was stimulated [45]. Moreover, Lee and col-
leagues (2020) found a marked increase of Aβ peptides in 
the cerebrospinal fluid space in the TUSS-treated 5xFAD 
mice, in which ligation of lymphatics to the deep cervi-
cal lymph nodes was performed (single session of 1 min) 
[56]. The data from this study suggest that, although the 
reactivity of glial cells has been reduced by TUSS, Aβ 
clearance could be ensured by the lymphatic system, 
which is possibly activated/stimulated by TUSS.
AS The 40-Hz AS has been shown to modulate the 
immune response in the brains of AD transgenic mice 
with intense Aβ plaque burden, by increasing microglial 
activity [30, 48] and astrocyte reactivity [30] (1  h/day, 
7 days period [30]; 2 h/day, 14 days period [48]). However, 
the one-week-long AS study observed that the increase 
in microglial activation induced by AS was reversed one 
week after the end of the treatment [30]. Both studies have 
reported a decrease in soluble and insoluble Aβ species 
[30, 48], possibly resulting from microglial activation. As 
the expression of inflammatory markers was not assessed, 
it was unknown if this increase in glial activation prompted 
or regulated neuroinflammation response. Importantly, 
combination of AS with visual stimulation delivered at 
40 Hz (1 h/day, 7 days period) induced microglia to dis-
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play a unique encapsulating effect around Aβ plaques 
throughout the brain of 5xFAD mouse, and this effect was 
not observed for any stimulus alone [30]. Importantly, this 
microglial activation results in decreased Aβ deposits in 
the brains of AD transgenic mice [30].
Neurotoxicity and neuroplasticity deficits
This section summarizes and discusses the effect of 
mechanical stimulation on different parameters of neu-
ronal malfunction and neurodegeneration in AD, such 
as neuronal loss, synaptic malfunction, deficits in neuro-
structural plasticity (e.g., dendritic atrophy, spine loss), 
among others. Unfortunately, there is a lack of evidence 
for WBV or AS from human or animal studies. There-
fore, this section only includes animal studies on TUSS.
TUSS treatment of various durations is associated 
with different beneficial effects against Aβ- and Tau-
induced toxicity and structural damage in the brains of 
AD transgenic mouse models. For instance, Shen (2019) 
and Lee (2020) led two experiments in which 1-Hz ultra-
sonic pulses (single session of 1  min) were applied to 
3xTg-AD and 5xFAD mice, respectively, which display 
advanced Aβ and Tau neuropathologies [56, 58]. The 
authors showed that the ultrasonic waves can modu-
late the proteomic profile in the brains of AD transgenic 
mice, which was correlated with enhanced neuronal 
function [58] and decreased neuronal loss [56] triggered 
by TUSS. In a study with longer TUSS stimulation, Bur-
gess et  al. (2014) found several morphological improve-
ments (i.e., increased number of immature neurons, total 
dendrite length, and dendrite branching in pre-existing/
mature neurons) in the hippocampus of TgCRND8 mice 
(8 min once a week, 3 weeks period) [38], supporting that 
the beneficial effect of TUSS was also affecting different 
parameters of brain plasticity.
Also, Karakatsani et  al. (2019) found that the brain 
slices from treated experimental animals show intact 
neural network integrity and neuronal morphology after 
unilateral target TUSS (single session of 1 min), indicat-
ing treatment safety [45]. Additionally, Pandit and others 
(2019) have found TUSS-evoked increased autophagy 
in neurons (but not in glial cells) in Tau-transgenic K3 
mice (2.4 min once a week, 15 weeks period) [66], show-
ing a US-driven improvement of neuronal proteostasis 
and increased Tau degradation after an extended treat-
ment period. Moreover, Eguchi and colleagues (2018) 
showed that TUSS in 5xFAD mice (60 min once a week, 
12  weeks period) leads to the upregulation of endothe-
lial nitric oxide synthase, neurotrophins, and heat-shock 
protein 90, accompanied by the downregulation of 
amyloid precursor protein (APP) and beta secretase-1 
(BACE-1), which are associated with a reduction of Aβ 
species and plaques throughout the brain after TUSS 
[57]. Importantly, Pandit et al. (2019) have also reported 
reduced p-Tau levels and neurofibrillary tangles in the 
hippocampus of an AD mouse model, possibly related 
with the increased autophagy [66]. Again, no clinical evi-
dence has been provided on the mitigation of neurotoxic-
ity after US treatment in humans.
Brainwave entrainment and brain functional connectivity
WBV Starting with this therapeutic modality, only one 
of the reviewed papers has assessed the impact of an eight-
week WBV program on neuronal activity of the human 
brain [67]. Specifically, this study reported increased 
brain network activity (assessed by electroencephalogra-
phy, EEG) overtime after 20-Hz to 40-Hz vertical vibra-
tion (frequency increased over treatment time) in women 
with senile dementia [67].
TUSS US treatment has also been proven to increase 
neuronal activity, despite the limited experimental evi-
dence on the topic. Indeed, among the reviewed studies, 
only one animal study has reported the occurrence of 
strong and transient entrainment of 40-Hz oscillations 
in the brains of 5xFAD mice during TUSS pulsing at the 
same frequency (single session of 1 h) [61]. At the clini-
cal level, two studies have reported alterations in brain 
networks after US therapy in AD patients. Meng and col-
leagues (2019) observed a decreased resting-state func-
tional connectivity in the right frontoparietal networks 
during BBB opening, although the functional organiza-
tion was restored at the one-day and one-week follow-
ups (2 US  sessions, one-month apart) [68]. In the same 
study, the US-treated patients showed a small tendency of 
increase of brain connectivity at the 3-month follow-up, 
both in the right frontoparietal and in the default mode 
networks [68]. In fact, Beisteiner et al. (2020) have stud-
ied the effect of 6–12 sessions delivered within the same 
time window – 1 month period – and detected enhanced 
memory networks, as well as increased steady-state and 
task-based functional connectivity in the hippocampus, 
cortex regions, and the precuneus, and in bilateral hip-
pocampi, respectively [69]. These findings suggest that 
transcranial US application could be effective in modulat-
ing brain activity and networks possibly by adopting fre-
quent sessions over a longer period. In addition, the brain 
network modulation is correlated with cognitive improve-
ments in AD patients, after both two- or four-week inter-
ventions [69]. Thus, it is quite plausible that the periodic-
ity of stimulation can greatly affect the effectiveness and 
durability of the treatment.
AS Five out of the six reviewed studies assessing the 
effect of AS (two preclinical and three clinical studies) 
have shown that AS is effective in increasing neuronal 
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activity [30, 31, 48, 49, 70]. The two preclinical AS stud-
ies observed increased gamma power after delivery of 
40-Hz intermittent sound waves in 3–8 month-old wild-
type (C57BL/6 J) mice (1 h/day, 7 days period) [30], and 
in 5xFAD transgenic mice (2 h/day, 14 days period) [48]. 
Interestingly, evoked gamma brain oscillations pro-
moted microglia aggregation in both transgenic mice 
and their wild-type littermates [48], suggesting that this 
immunomodulation response is not necessarily acti-
vated in response to Aβ and/or Tau pathologies. This 
brainwave entrainment was accompanied by increased 
functional connectivity in frontal gamma coupling with 
parietal delta at the baseline, which swapped to fron-
tal gamma coupling with parietal theta after TUSS [48]. 
However, an exaggerated increase of evoked gamma 
brainwaves was observed one day after the interven-
tion, which returned to baseline levels during the rest 
of the experiment [48], indicating an acute and tran-
sient response. In addition, Martorell et al. (2019) have 
shown that 40-Hz visual stimulation combined with AS 
delivered at the same frequency (1 h/day, 7 days period) 
shows a greater gamma oscillation entrainment fol-
lowed by decreased Aβ load in the brains of 5xFAD mice 
when compared to each of the stimuli alone.
In line with these findings, the first, and only so far, 
clinical evidence on the improvement of brain network 
activity after AS combined with visual stimulation in 
AD patients is provided by Calomeni and colleagues 
(2017) (15 min/day on alternate days, 20 days period) 
[49]. This study found that these sensory stimuli deliv-
ered at 8, 10, 12, 14, and 15  Hz (3  min/frequency) 
increase alpha (i.e. 8–15 Hz) brainwave activity in AD 
patients, but not in non-demented individuals [49], 
which is associated with memory gain [49]. Moreo-
ver, Papalambros and colleagues  performed two 
experiments in 2017 and 2019, in which they assessed 
the effect of 20-Hz AS (single session of 4  min deliv-
ered during sleep) on the neural activity in healthy 
non-demented older subjects [70] and patients with 
amnestic MCI, a precursor form of AD [71]. In the 
first study performed in healthy non-demented older 
subjects [70], a unique increase of slow-wave brain 
activity in the delta range (i.e. 0.5–4 Hz) during stim-
ulation is detected, accompanied by a small tendency 
of enhanced theta and fast spindle power. Moreo-
ver, increased signal amplitude and spindle density 
are observed during stimulation for all potentials, 
as assessed by EEG [70]. Importantly, the increased 
slow-wave activity (i.e. 0.5–4  Hz) is associated with 
better performance in word recall after stimulation 
[70]. By applying the same AS protocol to amnestic 
MCI patients, the authors have found increased slow-
oscillations (i.e. 0.5–1  Hz), slow-wave and sigma (i.e. 
9–15  Hz) activities during stimulation, whereas no 
effect was noticed in theta (4–7 Hz) or beta (16–20 Hz) 
bands [31]. Again, the alterations in neural activity are 
correlated with improved memory and cognition, as 
assessed by the cued-recall and verbal paired-associate 
tests, as well as by the NIH Toolbox Cognition Battery 
[31].
Behavioral performance
The reviewed studies typically present outcomes associ-
ated with motor and behavioral abilities. Twenty-seven 
out of the 37 analyzed papers provided evidence on the 
effect of mechanical vibration-based stimulation on 
motor and cognitive performance.
WBV
Despite the differences among the protocols (vibrations 
at 25 ± 15  Hz, 5-mm maximum amplitude, and hetero-
geneous sessions and treatment durations), studies have 
shown that the WBV treatment can improve different 
aspects of physical function, such as balance [21, 72–76], 
functional mobility [21, 72–79] and muscle mass and/or 
strength, mainly in the lower limbs [72, 76–78]. Impor-
tantly, three studies have reported an enhancement of 
quality-of-life  metrics after WBV training (6–9  weeks 
period) [21, 73, 78], which are directly associated with 
motor improvement, as well as with patients’ well-being 
[80]. In addition, Kim and Lee (2018) showed that WBV 
could improve cognitive function along with increased 
brain connectivity and plasticity in senile-demented 
women undergoing a WBV regimen with increasing 
frequency (20–40  Hz) of vibrations over time (4  min 
once a week, 2  months period) [67]. However, the ben-
eficial effect of WBV treatment in non-demented older 
adults remains unclear, as a WBV treatment of 10 weeks 
(1–5 min twice a week, 10 weeks period, with increasing 
training volume over time) described a small tendency 
(but not significant effect) of functional improvement 
as assessed by different motor ability tests like walking 
speed metrics [81]. Future studies should clarify whether 
the WVB treatment is also beneficial for non-demented 
older individuals.
TUSS TUSS is also associated with improvement of 
motor and cognitive skills in AD animal models, includ-
ing enhanced different types of memory (i.e. recogni-
tion, spatial, working, and short- and long-term memo-
ries) [36, 56, 58, 66], improved exploratory skills [36, 38, 
57] and improved motor ability and coordination [66]. 
Interestingly, after weekly sessions of 2.4-min delivery 
over 15  weeks (the longest of the reviewed protocols), 
no changes in grip strength (a motor-related parameter) 
were found in K3 mice. [66]. In addition, a study in aged 
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Aβ-positive dogs with advanced Aβ brain pathology 
found no significant changes in gait, postural reaction or 
cranial nerve testing after TUSS (2–3 min/ session, once a 
week, 4 weeks period) [62].
At the clinical level, Lipsman et al. (2018) did not find 
significant changes in cognition and daily functioning of 
AD patients at 3-month follow-up after TUSS (7.5  min 
once a week, 3 months period) [63]. However, in the same 
study, one of the five treated patients showed a transient 
cognitive improvement at 1-month follow-up [63]. Simi-
larly, other studies have detected no significant changes 
in cognitive function in AD patients after two to five ses-
sions of continuous ultrasonic waves (220-kHz center 
frequency) (2  weeks period), either at 30-day [82] or at 
1-week follow-up [65], independent of alterations in Aβ 
burden. On the other hand, one study has demonstrated 
that a US treatment delivered in 5-Hz ultrasonic pulses 
(2 to 4 weeks period) is able to improve cognitive perfor-
mance (e.g. enhanced memory and verbal processing) in 
a standardized neuropathological assessment defined at 
the Consortium to Establish a Registry for Alzheimer’s 
disease (CERAD), in a cohort of AD patients right after 
the treatment as well as three months later [69]. Impor-
tantly, the cognitive improvement of these AD patients 
is correlated with increased functional connectivity 
between different brain areas (e.g. hippocampus, parahip-
pocampal cortex, parietal cortex) [69].
AS For AS, a majority of evidence for its beneficial 
impact on behavioral performance has arisen from clini-
cal rather than animal studies. Only the animal study by 
Martorell et al. (2019) reported improved spatial memory 
and recognition in 5x-FAD mice after 40-Hz AS (1  h/
day, 7  days period), as assessed by different behavioral 
tests (i.e., Morris water maze, novel object recognition, 
and novel object location tasks) [30]. In human studies, 
multiple insights on behavioral performance and cogni-
tive function have been recently published. For instance, 
Papalambros et  al. assessed the impact of a 20-Hz AS 
intervention (single session of 4 min during sleep) in non-
demented elderly [70] and amnestic MCI patients [31] 
and found a positive effect on morning word-recall in 
MCI patients [31].
Finally, vibroacoustic stimulation (type of AS-) com-
bined with visual stimuli, both delivered at 40 Hz (30 min 
twice a week, 6  weeks period), improves cognitive per-
formance after stimulation in AD patients, as well as the 
awareness of surroundings, the interaction and discus-
sion/storytelling abilities, and alertness [83]. Overall, the 
data suggest that 40-Hz stimulation delivered in different 
rhythmic sensory-based modalities is a promising tool to 
improve different aspects of behavior.
Discussion
The ability of noninvasive, mechanical vibration strate-
gies to impact AD pathology and related behavioral defi-
cits has received increasing attention over the last years. 
Hereby, we provide a systematic review comparing and 
discussing cellular, molecular, functional, and behavioral 
outputs of three mechanical-based stimulation modali-
ties and the most promising protocols against the AD 
(Fig. 2).
Safety and feasibility of mechanical vibration‑based 
interventions
For the clinical implementation of any therapeutic 
modality, it is imperative to assess the safety and feasibil-
ity of the treatment. Particularly, WBV training requires 
a wise consideration of such parameters, especially in 
older individuals. These features have been extensively 
considered in the reviewed studies, as many of them 
are important for the participation of the elderly in the 
implemented programs, including the attendance rate, 
compliance, feedback provided by the participants, and 
adverse events. All the reviewed WBV protocols present 
a high attendance rate (> 74%) and treatment compliance 
(> 73%), and scarce adverse effects (e.g., muscle pain and 
discomfort) are reported after vibratory stimulation. The 
implemented protocols are well-tolerated by the major-
ity of the participants. For instance, while a 30-Hz WBV 
training protocol in demented patients is reported as 
enjoyable by the participants [84], another study of 26-Hz 
vibrations reported that the subjects felt high discom-
fort, forcing the protocol to be adapted to a vibration fre-
quency of 18 Hz; yet, the 18-Hz protocol was also poorly 
tolerated by the elderly [81]. These data suggest that the 
discomfort is not frequency-dependent, but possibly 
caused by a greater amplitude of vibration. Indeed, WBV 
protocols with vibration rates over 30  Hz have proved 
safe and well-tolerated by the elderly among the reviewed 
studies [21, 77, 79, 84]. In contrast, high-amplitude vibra-
tion should be avoided to prevent distress and dropouts 
from the WBV training. Importantly, the reviewed stud-
ies suggest that WBV protocols are suitable even for 
frail patients [76, 78, 81] and individuals with cognitive 
impairments [21, 67, 84], as they do not require any phys-
ical effort or ability and can also be personalized for each 
patient according to his anatomical and physiological fea-
tures. Taken together, these data demonstrate that WBV 
should be added to medical and rehabilitation therapies 
in older patients, enabling the enhancement of their neu-
romuscular performance and, possibly, cognitive skills.
Regarding the US modalities, the US-mediated BBB 
opening has proved safe, transient, and effective in all 
the reviewed protocols. No major adverse events occur 
and TUSS is well tolerated by all animals and patients. 
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However, among the studies reviewed, no long-term 
effects were assessed, with the longest follow-up period 
in AD patients being three months [69]. Neverthe-
less, a study in healthy non-human primates employing 
repeated ultrasonic waves over four to 20  months has 
reported no damage in the animal brain, and no altera-
tions in health status (e.g., respiration rate, blood pres-
sure, and  O2 level) throughout the intervention [85]. 
These findings support the long-term safety of US treat-
ment in primates, but this issue needs to be addressed 
in future transcranial US studies in both demented and 
non-demented patients, mainly after multiple-sonica-
tion protocols. Importantly, to prevent tissue damage 
and ensure appropriate sonication power, some of the 
reviewed studies [38, 63, 68] used an acoustic feedback 
controller algorithm proposed by O’Reilly and Hynynen 
(2012) [86] that allows the real-time monitoring of acous-
tic emissions. The system detects subharmonic emis-
sions that indicate enhanced microbubble activity, and 
responds by reducing the applied acoustic pressure in the 
stimulation site. This enables the control of ultrasound 
emission according to microbubble response, avoiding 
in situ pressure fluctuations due to skull thickness or vas-
culature variations among individuals [38]. This repre-
sents an important development in the field in terms of 
clinical translation of TUSS for AD, contributing to good 
tolerability and safety.
Finally, sparse information exists on the safety and fea-
sibility of AS protocols since this sensory modality does 
not require any effort, or induce any pain or discomfort 
in participants. In fact, when applied overnight, both 
healthy non-demented older adults and amnestic MCI 
patients report no changes in sleep quality and sleep-
staging features [31, 70], suggesting that AS is comfort-
able and suitable even for demented elderly persons.
Most relevant outcomes of multi‑mechanical stimulation
Based on the reviewed studies (Table  5), we found that 
the main outcomes associated with the WBV program in 
the elderly are improvement of different aspects of motor 
performance, such as mobility and balance skills, as well 
as increased muscle mass and/or strength. The majority 
of the reviewed studies have reported enhancement of at 
least one of these parameters, although a wide variety of 
WBV protocols have been implemented. Intriguingly, we 
noticed some divergent outcomes even for similar inter-
vention parameters. We  assume that this divergency 
is associated with differences in the patient’s physical/
motor status at baseline. As suggested by Lam (2017), 
worse baseline physical/motor status allows for a greater 
gain of physical and/or cognitive performance after WBV 
treatment [21], which can explain the lack of signifi-
cant results in some studies due to insufficient mobility 
impairment, and so, less improvement. Although this 
approach seems to be more efficient in people with worse 
neuromuscular function, this does not mean that non-
frail subjects cannot benefit from WBV training. In fact, 
many studies have reported marked improvement of 
motor and cognitive performances in young and healthy 
adults [87–90]. Future studies in older individuals should 
address the baseline functional mobility and cognitive 
status to understand the suggested reversed relationship 
between improvement and health status.
Nevertheless, it has been demonstrated that the imple-
mentation of WBV training programs in demented and 
cognitively impaired individuals is effective in improving 
the overall neuromuscular function, functional mobil-
ity, and metrics related to the quality of life [21, 73, 78]. 
Simultaneously, this training may also improve disrupted 
brain networks and many aspects of cognitive function, 
such as orientation, memory, and linguistic skills [67]. 
Importantly, by enhancing the overall motor ability, WBV 
exercise may constitute an effective strategy to prevent 
falls and therefore bone fractures [76, 91], as well as brain 
damage due to trauma, which are common in advanced 
age [92, 93]. Furthermore, the improved neuronal activity 
and cognitive enhancement induced by WBV in senile-
demented women [67] point towards further investiga-
tion on the effect of WBV on cognitive status and brain 
pathology in AD or demented patients.
On the other hand, TUSS can provide noninvasive 
immunoregulation and neuromodulation reversing AD 
pathomechanisms. Glial cells play a critical role in main-
taining the balance in the nervous system, mainly  when 
something disrupts its functioning. For instance, in 
the AD brain, microglia and astrocytes play an essen-
tial role in controlling the levels of aggregated proteins 
(mainly Aβ), promoting their clearance. For this reason, 
many researchers have focused on immunotherapies to 
increased Aβ clearance through administration of immu-
notherapeutic agents, both related and non-related with 
microglial activation [94], although non-satisfactory 
results have been obtained in clinical trials [95]. Here, 
many of the TUSS studies have shown activation of dif-
ferent immune cells, enhanced co-localization with Aβ 
and Tau followed by reduced Aβ or Tau accumulation in 
the brains of different AD transgenic mouse models [38, 
66]. In fact, several researchers have reported enhanced 
co-localization of microglia around Aβ or Tau aggregates 
in the brains of AD transgenic mice after US stimula-
tion [36, 45, 56–61] as well as 40-Hz AS combined with 
visual stimulus in 5xFAD mice [30]. Importantly, these 
alterations are accompanied by a reduction of Aβ or 
Tau deposits [45, 56–59, 61]. Stimulated by Iaccarino 
et  al. (2016) who used 40-Hz visual stimulation to pro-
duce gamma brainwave entrainment in the brains of AD 
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transgenic mice, many research efforts have provided 
strong evidence about the effectiveness of TUSS puls-
ing at low frequency. For instance, 5-Hz and 40-Hz USS 
modulate brain network activity in AD transgenic mice 
[61] and patients [69], respectively. Moreover, pulsed 
TUSS evoked neurogenesis and dendritic growth in the 
hippocampus of TgCRND8 mice [38, 57]. This evidence 
supports the growing interest in ultrasonic wave-based 
treatments to fight against AD brain pathology, not only 
by blocking or reversing Aβ and/or Tau pathology but 
also by attenuating inflammation, neuronal and synaptic 
loss, and altered brain activity.
As AD patients present abnormalities in gamma oscil-
lations that are essential for high-order cognitive func-
tions, such as information storage and retrieval [54], 
these brainwaves have been used as a target in emerging 
strategies to address altered brain networks in the AD 
brain. The sensory-based modalities delivered as rhyth-
mic stimuli, which particularly focus on the gamma fre-
quency band, have gained major attention in the last five 
years to improve altered brain oscillations; increased 
brainwave power and synchronization seem to affect Aβ 
and/or Tau pathologies [30, 48, 51, 54]. In fact, the asso-
ciation between brainwave entrainment and AD neuro-
pathology has been widely studied, as researchers have 
found that the entrained brain oscillations can modulate 
AD neuropathology, reducing Aβ and/or Tau pathology 
[51, 54, 96]. Moreover, other frequency bands have also 
been associated with memory and cognitive enhance-
ments. For instance, visual and auditory stimuli deliv-
ered at alpha and beta frequency bands can increase 
brain oscillations in EEG signals associated with mem-
ory enhancement [49]. Interestingly, these stimuli affect 
brainwave activity differently according to the conditions 
of the participants, as the applied therapy increases alpha 
activity in the brains of AD patients while no significant 
effect was produced in patients with Parkinson’s disease 
and non-demented older individuals [49]. This suggests 
that the applied protocol is more effective in improv-
ing neuronal network dysfunctions associated with AD 
neuropathology. Similarly, Papalambros et  al. (2017 
and 2019) observed increased slow-wave activity (i.e. 
0.5–4 Hz) in both non-demented and demented patients 
after 20-Hz AS (beta frequency band) overnight, which is 
correlated with cognitive enhancement [31, 70]. Interest-
ingly, these studies show that the increased power of spe-
cific brainwaves is not necessarily associated with stimuli 
delivered in the same frequency band, suggesting that 
rhythmic AS can increase brain activity across different 
frequency bands.
Most promising protocols for clinical application
In WBV studies, the passive exercise training is deliv-
ered using two distinct vibration modes, namely verti-
cal and rotational vibration. These modes differ in terms 
of vibration mechanisms, the direction of vibration, and 
stimulated muscles, and hence they can produce different 
outcomes in similar cohorts. For this reason, it is impor-
tant to clarify which aspects of these vibration modes can 
lead to beneficial or detrimental effects in the frail elderly. 
On the one hand, mechanical acceleration in rotational 
vibration is performed in the anterior–posterior axis [14], 
which is coincident with the direction in which the lower 
limb balance declines over the aging process; rotational 
vibration can also cause muscle and joint pain [97]. How-
ever, rotational vibration has been proven to promote an 
increase in muscle strength, which has been associated 
with the increased balance and functional mobility [77, 
98]. On the other hand, in the WBV training with vertical 
vibration, the platform moves up and down, which mobi-
lizes all body weight, toning muscles and strengthening 
bones [99]. As both types of vibration are associated with 
positive outcomes, further investigations should com-
pare and assess the impact of different directions of the 
vibration in the elderly and particularly AD patients. In 
addition, many studies have used a WBV protocol with 
progressively increased frequency of vibration over time, 
which is associated with marked improvements in neuro-
muscular performance and/or quality of life [73, 77–79]. 
This suggests that increasing the training intensity dur-
ing the WBV treatment may elicit more beneficial effects 
than using a constant vibration frequency. In summary, 
data extracted from the reviewed studies suggest that 
the main parameters to be employed in future AD clini-
cal research on WBV protocols are: (i) vertical vibra-
tion, as only this type of vibration is used for cognitively 
impaired subjects; (ii) pulse frequency of 20–40 Hz, with 
special emphasis on 30-Hz vibration and increased fre-
quency over time; (iii) amplitude of vibration of 2  mm; 
and (iv) a training volume of 4–6 min per session, two to 
four sessions per week over five/six consecutive weeks. 
Importantly, although the treatment parameters among 
cohorts are quite similar, there is a tendency for shorter 
treatment (i.e., lower duration) employed in demented 
patients compared with non-demented subjects.
Considering TUSS in patients with AD or dementia, 
the effectiveness needs to be preceded by a demonstra-
tion of the intervention safety, mainly due to the poten-
tial thermal and damaging effects produced by the US 
when applied at a high frequency. For this reason, and 
given the information provided in Table 3, we believe that 
future protocols designed to affect AD pathology should 
consider: (i) the frequency of the pulse, as most of the 
reviewed preclinical studies used intermittent stimulation 
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(commonly from 1 to 10 Hz [36, 37, 58, 66, 69], although 
40-Hz TUSS was shown to produce strong but transient 
signal entrainment in the brains of AD transgenic mice 
[61]); (ii) the delivery mode, as the whole-brain stimula-
tion (e.g. through a helmet-like device) seems to be the 
most appropriate option to produce a widespread effect 
over the brain, although localized sonication has proved 
to affect further brain regions in mice [45, 56, 59]; and 
(iii) the number of sonications, as a minimum of six ses-
sions are required.
Finally, concerning the application of AS in AD and 
cognitively impaired patients, the most important 
parameters for the effect of AS on AD pathology are: (i) 
pulsing rate of 40 Hz, which represents the most prom-
ising option (essentially based on AD transgenic mice 
studies); and (ii) stimulation volume of 15- to 30-min ses-
sions, at least once per week, over a minimum of three 
weeks. However, a single session of overnight AS dur-
ing sleep is also effective in increasing slow-wave activ-
ity and enhancing memory recall in non-demented older 
adults [70] and in amnestic MCI [31], which means that 
AS delivery during sleep should be further investigated in 
AD patients in future trials.
Overall, the reviewed protocols show that various com-
binations of protocol specifications can be employed 
to improve different aspects of AD pathology and to 
improve cognition and other behavioral aspects. Cur-
rently, quite similar treatment parameters have been 
employed in both demented and non-demented subjects. 
In further studies in AD and demented patients, it is nec-
essary to determine which protocol specifications should 
be employed to impact AD pathology.
Limitations and future directions
The main limitation associated with the reviewed stud-
ies is the lack of histological/biochemical and/or imaging 
assessment of key biomarkers, such as Aβ and Tau spe-
cies, and neuronal damage/inflammation markers in the 
brains of participants. This monitoring would enable fur-
ther advances in the development of mechanical-based 
treatments to block AD pathomechanisms. Most of the 
studies performed in humans essentially focus on brain 
network activity and motor and behavioral improve-
ments, while only three studies have monitored altera-
tions at biochemical and functional/structural levels (e.g., 
serological analysis to assess biomarkers, and brain imag-
ing techniques such as PET and MRI) after mechanical 
wave treatment [63, 65, 100]. Therefore, additional stud-
ies that use mechanical-based stimulation modalities and 
report biochemical and imaging brain data are needed to 
clearly describe the bioeffects of mechanical-based stim-
ulation modalities on different molecular and metabolic 
aspects of AD neuropathology.
Moreover, longer follow-up periods are needed to 
test the effect of detraining or treatment suspension, 
as most of the reviewed studies with a follow-up period 
have reported a decline/reverse of the positive effect 
right after the treatment [37, 59, 63, 76]. In fact, no 
clinical data have been published so far on the long-
term effect of these stimulation modalities, so a longer 
study span is needed in the future.
In addition, many of the reviewed studies present a 
lack of important information related to protocol speci-
fications, e.g. the amplitude of vibration [67, 75] and 
the type of vibration [84] in WBV protocols, as well as 
the US center frequency [69] and pulsing rate [63, 65, 
82] in TUSS studies. Other parameters such as the con-
tact area and pressure of transducer on the heads of 
animals/patients, the distance and angle between the 
transducer and the head, the duty cycle, and the inten-
sity of acoustic signal (e.g., power density) are required 
to fully characterize the mechanical stimulation pro-
tocol, which allows for reproducibility in experiments 
and a reliable comparison among different studies.
Conclusions
Latest studies have reported the effectiveness, safety, and 
feasibility of mechanical waves delivered through differ-
ent stimulation modes to mitigate AD pathology and to 
improve the overall physical and behavioral performance 
of AD patients, demented individuals, and non-demented 
elderly persons. Importantly, clinical evidence from AD 
and demented patients has accumulated over the past 
five years, and promising results have been generated. 
Based on the current evidence, the low-cost and nonin-
vasive mechanical-based interventions can contribute to 
the development of an alternative effective solution to 
fight AD neuropathology and related behavioral deficits. 
However, there is limited evidence on the comparison 
between treatment specifications, and hence, suboptimal 
and quite distinct protocols have been employed. This 
comparison is crucial to further optimize the stimulation 
protocols in order to maximize their therapeutic poten-
tial. Nevertheless, the effectiveness of the mechanical-
based stimulation strategies in promoting physiological 
and electrochemical alterations that could mitigate AD 
pathology will certainly evolve in the future and, hope-
fully, revolutionize AD therapeutics in the upcoming 
decades.
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Fig. 2 Schematic representation of the main mechanical vibration effects on AD pathology and age-related impairments. Created with BioRender.
com
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